DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» CDKN2C
CDKN2C
Expression Profiling of KLF4
Charles M. Perou, Phd Associate Professor Departments of Genetics
Supplemental Table S1 (A): Microarray Datasets Characteristics
Tagging Single Nucleotide Polymorphisms in Cell Cycle Control Genes and Susceptibility to Invasive Epithelial Ovarian Cancer
CDKN2C-Null Leiomyosarcoma: a Novel
Co-Deletion of P18 and P16 /P14 /P15 in Glioblastoma Multiforme
Deletions of CDKN2C in Multiple Myeloma: Biological and Clinical Implications Paola E
Autoimmunity in a Mouse Model of Lupus Deficiency Promotes B1a
Cdkn2a, the Cyclin-Dependent Kinase Inhibitor Encoding P16ink4a and P19arf, Is a Candidate for the Plasmacytoma Susceptibility Locus, Pctr1
Inhibition of CDK4/6 As Therapeutic Approach for Ovarian Cancer Patients: Current Evidences and Future Perspectives
The Role of Cdks and Cdkis in Murine Development
MEN4 and CDKN1B Mutations 24:10 T195–T208 Thematic Review
Mutations in CDKN2C (P18) and CDKN2D (P19) May Cause Sporadic Parathyroid Adenoma
CDKN2C: a Cell-Cycle Gene Duplicated in the Bowhead Whale Background
Oxidized Phospholipids Regulate Amino Acid Metabolism Through MTHFD2 to Facilitate Nucleotide Release in Endothelial Cells
Effects of Flavonoids on Expression of Genes Involved in Cell Cycle
Cell Cycle Arrest Through Indirect Transcriptional Repression by P53: I Have a DREAM
Targeting DNA Repair, Cell Cycle, and Tumor Microenvironment in B Cell Lymphoma
Top View
Germline Mutations in the CDKN2B Tumor Suppressor Gene Predispose to Renal Cell Carcinoma
Cell Cycle Arrest Protein CDKN2C Is Not an HBV Host Factor
CCND1 and CDKN1B Polymorphisms and Risk of Breast Cancer
DATASHEET Cyclin Dependent Kinase 4 Inhibitor C (CDKN2C
Predicting Response to Platin Chemotherapy Agents with Biochemically-Inspired Machine Learning
Signaling Through Cyclin D-Dependent Kinases
Haematology Probes for Multiple Myeloma MULTIPLE MYELOMA
Identification of Important Cell Cycle Regulators And
Lack of Imprinting of Three Human Cyclin-Dependent Kinase Inhibitor Genes'
UCLA Previously Published Works
Cyclin-Dependent Kinase 4 and 6 Inhibitors in Cell Cycle Dysregulation for Breast Cancer Treatment
Stat3β Enhances Sensitivity to Concurrent Chemoradiother-Apy by Inducing Cellular Necroptosis in Esophageal Squamous Cell Carcinoma
Pattern of Retinoblastoma Pathway Inactivation Dictates Response to CDK4/6 Inhibition in GBM
Differentially Expressed Genes on the Growth of Mouse Leydig Cells Treated with Standardised Eurycoma Longifolia Extract
Cyclin-Dependent Protein Kinase Inhibitors Including Palbociclib As
Pharmacologic Inhibition of Cyclin-Dependent Kinase 4/6 Activity Arrests Proliferation in Myoblasts and Rhabdomyosarcoma-Derived Cells
1 CDKN2C Homozygous Loss Identifies a Distinct Subtype of TP53/RB1-Wildtype Leiomyosarcoma with Frequent CIC Genomic Alterations
Oncology Gene List
Gh G2M Pathway Score Pancreatic Cancer Is Associated with Worse Survival, Particularly After Margin-Positive (R1 Or R2) Resection
Anti-CDKN2C (GW22054F)
Cyclin D As a Therapeutic Target in Cancer
Polymorphisms of Cell Cycle Control Genes Influence the Development Of
Disruption of Pathways Regulated by Integrator Complex in Galloway–Mowat Syndrome Due to WDR73 Mutations F
Frequent Inactivation of the Cyclin-Dependent Kinase
Cyclin-Dependent Kinase Inhibitors in Hematological Malignancies—Current Understanding, (Pre-)Clinical Application and Promising Approaches
Targeting CDK4 and CDK6: from Discovery to Therapy
Table S3. up Or Down Regulated Genes in Tcof1 Over-Expressed
CDK2 Transcriptional Repression Is an Essential Effector in P53
Mutations in CDKN2C (P18) and CDKN2D (P19) May Cause Sporadic Parathyroid Adenoma
Targeting CDK4 and CDK6: from Discovery to Therapy
Direct CDKN2 Modulation of CDK4 Alters Target Engagement of CDK4 Inhibitor Drugs
Pattern of Retinoblastoma Pathway Inactivation Dictates Response to CDK4/6 Inhibition in GBM